RG

Rajni Gaurishankar Patle

Active Director Director DIN 09651082
DIN 09651082 First appointment Jun 2022 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajni Gaurishankar Patle

Data last updated:

Rajni Gaurishankar Patle is a Director at Anita Oncology Network Private Limited (since 2022). The company operates in Non-Profit Organizations.

DIN 09651082
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 24 Jun 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Jun 20222022Active

Board colleagues of Rajni Gaurishankar Patle

NameDINCompanyDesignation
Vaibhav Choudhary09651081Anita Oncology Network Private LimitedDirector

Directorship timeline

Open interactive timeline →
Anita Oncology Network Private Limited
Premium access

Shareholding and investment profile for Rajni Gaurishankar Patle

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajni Gaurishankar Patle

Rajni Gaurishankar Patle currently holds 1 directorship: Anita Oncology Network Private Limited (Director, since 24 Jun 2022).

Rajni Gaurishankar Patle was first appointed on 24 Jun 2022 as Director at Anita Oncology Network Private Limited.

The current boards of Rajni Gaurishankar Patle's companies include Vaibhav Choudhary (Anita Oncology Network Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available